# PROCTER & GAMBLE Co: Form 10-Q for the period ended Mar 31, 2017

- Company: [PROCTER & GAMBLE Co](/companies/pg.md) (CIK 80424)
- Form: 10-Q
- Filed: 2017-04-26
- Accepted by EDGAR: Apr 26, 2017, 20:04 ET
- Period: 2017-03-31
- Accession: 0000080424-17-000026
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/80424/000008042417000026/fy1617q3jfm10-qreport.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/80424/000008042417000026/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2017-01-01 to 2017-03-31 | $15.61bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months, 2016-07-01 to 2017-03-31 | $48.98bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2017-01-01 to 2017-03-31 | $7.84bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2016-07-01 to 2017-03-31 | $24.24bn | us-gaap:CostOfGoodsSold |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $4.41bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2016-07-01 to 2017-03-31 | $13.74bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-03-31 | $3.36bn | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2016-07-01 to 2017-03-31 | $11.01bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-01-01 to 2017-03-31 | $96.0m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2016-07-01 to 2017-03-31 | $349.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-01-01 to 2017-03-31 | $780.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2016-07-01 to 2017-03-31 | $2.34bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | $2.52bn | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2016-07-01 to 2017-03-31 | $13.11bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.93 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2016-07-01 to 2017-03-31 | $4.76 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-01-01 to 2017-03-31 | $0.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2016-07-01 to 2017-03-31 | $4.95 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-01-01 to 2017-03-31 | 2,705,500,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2016-07-01 to 2017-03-31 | 2,755,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2016-07-01 to 2017-03-31 | $9.06bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2016-07-01 to 2017-03-31 | $2.23bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months, 2016-07-01 to 2017-03-31 | $5.41bn | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months, 2016-07-01 to 2017-03-31 | $4.50bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-03-31 | $5.82bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $25.89bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $118.09bn | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $29.08bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $63.54bn | us-gaap:Liabilities |
| Long-term debt | at 2017-03-31 | $16.63bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2017-03-31 | $13.78bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-03-31 | $54.55bn | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
| Shares outstanding | at 2017-03-31 | 2,557,614,388 shares | dei:EntityCommonStockSharesOutstanding |

## Management's discussion and analysis

As filed, 73,419 characters.

### Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” “Risk Factors,” and Notes 4 and 10 to the Consolidated Financial Statements. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise.

Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including commodity prices, raw materials, labor costs, energy costs and pension and health care costs; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third party relationships, such as our suppliers, contractors and external business partners; (11) the ability to rely on and maintain key information technology systems and networks (including Company and third-party systems and networks) and maintain the security and functionality of such systems and networks and the data contained therein; (12) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, intellectual property, antitrust, privacy, tax, accounting standards and environmental) and to resolve pending matters within current estimates; (13) the ability to manage changes in applicable tax laws and regulations; (14) the ability to successfully manage our portfolio optimization strategy, including achieving and maintaining our intended tax treatment of the related transactions, and our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; (15) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining particularly key employees, especially in key growth markets where the availability of skilled or experienced employees may be limited; and (16) the ability to manage the uncertain implications of the United Kingdom’s withdrawal from the European Union. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein is included in the section titled "Economic Conditions and Uncertainties" and the section titled “Risk Factors” (Part II, Item 1A of this Form 10-Q).

The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying notes. The MD&A is organized in the following sections:

- Overview
- Summary of Results – Nine Months Ended March 31, 2017
- Economic Conditions and Uncertainties
- Results of Operations – Three and Nine Months Ended March 31, 2017
- Business Segment Discussion – Three and Nine Months Ended March 31, 2017
- Liquidity and Capital Resources
- Reconciliation of Measures Not Defined by U.S. GAAP

Throughout the MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, core net earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures as well as details on the use and the derivation of these measures.

Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in the MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category.

### OVERVIEW

P&G is a global leader in fast-moving consumer goods, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in more than 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies. We have on-the-ground operations in approximately 70 countries.

Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.

The table below provides detail on our reportable segments, including the product categories and brand composition within each segment.

| Reportable Segments | Product Categories (Sub-Categories) | Major Brands |
| --- | --- | --- |
| Beauty | Hair Care (Conditioner, Shampoo, Styling Aids, Treatments) | Head & Shoulders, Pantene, Rejoice |
| Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care) | Olay, Old Spice, Safeguard, SK-II |  |
| Grooming | Grooming (1) (Shave Care - Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care; Appliances) | Braun, Fusion, Gillette, Mach3, Prestobarba, Venus |
| Health Care | Oral Care (Toothbrushes, Toothpaste, Other Oral Care) | Crest, Oral-B |
| Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care) | Prilosec, Vicks |  |
| Fabric & Home Care | Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents) | Ariel, Downy, Gain, Tide |
| Home Care (Air Care, Dish Care, P&G Professional, Surface Care) | Cascade, Dawn, Febreze, Mr. Clean, Swiffer |  |
| Baby, Feminine & Family Care | Baby Care (Baby Wipes, Diapers and Pants) | Luvs, Pampers |
| Feminine Care (Adult Incontinence, Feminine Care) | Always, Tampax |  |
| Family Care (Paper Towels, Tissues, Toilet Paper) | Bounty, Charmin |  |

(1) The Grooming product category is comprised of the Shave Care and Appliances Global Business Units.

The following table provides the percentage of net sales and net earnings by reportable business segment for the three and nine months ended March 31, 2017 (excluding net sales and net earnings in Corporate):

|  | Three Months Ended March 31 Net Sales | Net Earnings | Nine Months Ended March 31 Net Sales | Net Earnings |
| --- | ---: | ---: | ---: | ---: |
| Beauty | 17% | 18% | 18% | 20% |
| Grooming | 10% | 15% | 10% | 16% |
| Health Care | 12% | 14% | 12% | 13% |
| Fabric & Home Care | 32% | 28% | 32% | 26% |
| Baby, Feminine & Family Care | 29% | 25% | 28% | 25% |
| **Total Company** | **100%** | **100%** | **100%** | **100%** |

### SUMMARY OF RESULTS

Following are highlights of results for the nine months ended March 31, 2017 versus the nine months ended March 31, 2016:

- Net sales were unchanged versus the previous period at $49.0 billion. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 2%. Organic sales increased 2% in Beauty, 7% in Health Care, 2% in Fabric & Home Care, 1% in Baby, Feminine & Family Care and were unchanged in Grooming.
- Unit volume increased 1% with organic volume up 2%. Volume increased mid-single digits in Health Care and low single digits in Fabric & Home Care, Baby, Feminine & Family Care and Grooming. Volume decreased low single digits in Beauty. Excluding the impacts of minor brand divestitures, organic volume increased low single digits in Beauty.
- Net earnings from continuing operations were $8.0 billion, unchanged versus the prior year period. An increase in operating income, primarily driven by gains on the sale of real estate, and the benefit of a lower effective tax rate were offset by an increase in other non-operating expense due mainly to a charge related to early extinguishment of certain long-term debt.
- Diluted net earnings per share from continuing operations increased 3% to $2.87 due to reduced shares outstanding from shares tendered in the divestiture of the Beauty Brands to Coty.
- Net earnings attributable to Procter & Gamble were $13.1 billion, an increase of $4.6 billion or 53% versus the prior year period, primarily driven by the $5.3 billion after-tax gain on the sale of the Beauty Brands in the current period partially offset by the base-period results of discontinued operations, including the net results of the Beauty Brands and a gain on the sale of the Batteries business.
- Core net earnings attributable to Procter & Gamble, which excludes discontinued operations, the charge related to early extinguishment of certain long-term debt and incremental restructuring charges, increased 3% to $8.5 billion. Core net earnings per share increased 7% to $3.07 due to the increase in core net earnings and the reduction in shares outstanding.
- Operating cash flow was $9.1 billion. Adjusted free cash flow, which is operating cash flow less capital expenditures and excluding tax payments related to the sale of the Beauty Brands, was $7.0 billion. Adjusted free cash flow productivity, which is the ratio of adjusted free cash flow to net earnings excluding a loss on early debt extinguishment and the gain on sale of the Beauty business, was 86%.

### ECONOMIC CONDITIONS AND UNCERTAINTIES

***Global Economic Conditions.*** Current macroeconomic factors remain dynamic, and any causes of market size contraction, such as reduced GDP in commodity-dependent economies, greater political unrest in the Middle East and Eastern Europe, further economic instability in the European Union, political instability in certain Latin American markets and economic slowdowns in Japan and China, could reduce our sales or erode our operating margin, in either case reducing our earnings.

***Changes in Costs.*** Our costs are subject to fluctuations, particularly due to changes in commodity prices and our own productivity efforts. We have significant exposures to certain commodities, in particular certain oil-derived materials like resins, and volatility in the market price of these commodity input materials has a direct impact on our costs. If we are unable to manage commodity fluctuations through pricing actions, cost savings projects and sourcing decisions as well as through consistent productivity improvements, it may adversely impact our gross margin, operating margin and net earnings. Sales could also be adversely impacted following pricing actions if there is a negative impact on consumption of our products. We strive to implement, achieve and sustain cost improvement plans, including outsourcing projects, supply chain optimization and general overhead and workforce optimization. As discussed later in this MD&A, we initiated certain non-manufacturing overhead reduction projects along with manufacturing and other supply chain cost improvements projects in 2012. If we are not successful in executing and sustaining these changes, there could be a negative impact on our operating margin and net earnings.

***Foreign Exchange.*** We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. Over the past four years, the U.S. dollar has strengthened versus a number of foreign currencies leading to lower sales and earnings from these foreign exchange impacts. Certain countries experiencing significant exchange rate fluctuations, like Argentina, Egypt, Nigeria, and the United Kingdom have had, and could continue to have, a significant impact on our sales, costs and earnings. Increased pricing in response to these fluctuations in foreign currency exchange rates may offset portions of the currency impacts but could also have a negative impact on consumption of our products, which would affect our sales.

***Government Policies.*** Our net earnings could be affected by changes in U.S. or foreign government tax policies. For example, the U.S. is considering corporate tax reform that may significantly impact the corporate tax rate and change the U.S. tax treatment of international earnings. Additionally, we attempt to carefully manage our debt and currency exposure in certain countries with currency exchange, import authorization and pricing controls, such as Nigeria and Ukraine. Changes in government policies in these areas might cause an increase or decrease in our sales, operating margin and net earnings. For example, during fiscal 2015, the Company deconsolidated its Venezuelan subsidiaries due to evolving conditions that resulted in an other-than-temporary lack of exchangeability between the Venezuelan bolivar and U.S. dollar and restricted our ability to pay dividends and satisfy certain other obligations denominated in U.S. dollars.

For information on risk factors that could impact our results, please refer to Part II, Item 1A "Risk Factors" in the Company’s Form 10-Q for the quarterly period ended December 31, 2016.

### RESULTS OF OPERATIONS – Three Months Ended March 31, 2017

The following discussion provides a review of results for the three months ended March 31, 2017 versus the three months ended March 31, 2016.

*Amounts in millions, except per share amounts*

|  | Three Months Ended March 31 2017 | 2016 | % Chg |
| --- | ---: | ---: | ---: |
| Net sales | **$15,605** | $15,755 | (1)% |
| Operating income | **3,360** | 3,318 | 1% |
| Net earnings from continuing operations | **2,556** | 2,337 | 9% |
| Net earnings from discontinued operations | **—** | 446 | (100)% |
| Net earnings attributable to Procter & Gamble | **2,522** | 2,750 | (8)% |
| Diluted net earnings per common share | **0.93** | 0.97 | (4)% |
| Diluted net earnings per share from continuing operations | **0.93** | 0.81 | 15% |
| Core net earnings per common share | **0.96** | 0.86 | 12% |
|  | **Three Months Ended March 31** |  |  |
| **COMPARISONS AS A % OF NET SALES** | **2017** | **2016** | **Basis Pt Chg** |
| Gross profit | **49.8%** | 49.8% | — |
| Selling, general & administrative expense | **28.3%** | 28.7% | (40) |
| Operating income | **21.5%** | 21.1% | 40 |
| Earnings from continuing operations before income taxes | **21.4%** | 20.5% | 90 |
| Net earnings from continuing operations | **16.4%** | 14.8% | 160 |
| Net earnings attributable to Procter & Gamble | **16.2%** | 17.5% | (130) |

### Net Sales

Net sales for the quarter decreased 1% to $15.6 billion. Unit volume was unchanged. Unfavorable foreign exchange reduced net sales by 2%. Pricing and mix had no net impact on consolidated net sales. Volume increased mid-single digits in Health Care and low single digits in Baby, Feminine & Family Care. Volume was unchanged in Fabric & Home Care and Grooming and decreased low single digits in Beauty driven by minor brand divestitures. Volume increased low single digits in developed regions and was unchanged in developing regions. Organic sales increased 1% driven by a 1% increase in organic volume.

|  | Net Sales Change Drivers 2017 vs. 2016 (Three Months Ended March 31)\* Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other\*\* | Net Sales Growth |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Beauty | (2)% | —% | (1)% | 1% | —% | —% | (2)% |
| Grooming | —% | —% | —% | (2)% | (4)% | —% | (6)% |
| Health Care | 4% | 4% | (1)% | 1% | 1% | (1)% | 4% |
| Fabric & Home Care | —% | 1% | (2)% | —% | —% | 1% | (1)% |
| Baby, Feminine & Family Care | 1% | 1% | (1)% | —% | —% | (1)% | (1)% |
| **Total Company** | **—%** | **1%** | **(2)%** | **—%** | **—%** | **1%** | **(1)%** |

\* Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

\*\* Other includes the sales mix impact from acquisitions/divestitures and rounding impacts necessary to reconcile volume to net sales.

### Operating Costs

Gross margin was unchanged at 49.8% of net sales for the quarter. Gross margin benefited from a 210 basis point impact from total manufacturing cost savings (180 basis points net of product and packaging reinvestments), a 40 basis point impact from lower incremental restructuring charges and a 10 basis point impact from increased volume scale leverage. These impacts were offset by a 100 basis point decline from unfavorable product mix (primarily between segments caused by the disproportionate net sales declines in Beauty and Grooming, both of which have higher than company-average gross margins, and within segments due to disproportionate growth of lower margin products), a 80 basis point decline due to higher commodity costs, a 20 basis point negative impact from unfavorable foreign exchange and 30 basis points from other impacts, including costs incurred from tornado damage to a U.S. Family Care distribution facility.

Total SG&A spending decreased 2% to $4.4 billion as a reduction in other operating expense, primarily from a gain on the sale of real estate, was partially offset by increases in marketing and overhead spending. SG&A as a percentage of net sales decreased 40 basis points to 28.3%, as a 130 basis point benefit in other operating income, including the gain on the sale of real estate, was partially offset by increases in overhead and marketing as a percent of net sales. Overhead costs as percent of net sales increased 70 basis points as wage inflation and investments in R&D and sales resources were partially offset by cost savings. Marketing spending as a percent of net sales increased 20 basis points as investments in advertising were partially offset by reductions in agency compensation. Overall cost savings delivered 50 basis points of benefit in SG&A.

### Non-Operating Expenses and Income

Interest expense was $96 million for the quarter, a decrease of $50 million versus the prior year period, due to a decrease in weighted average interest rates and a decline in the average debt outstanding. Interest income was $46 million for the quarter, an increase of $13 million versus the prior year period due to an increase in interest-bearing cash and cash equivalents. Other non-operating income/(loss) was $26 million, an increase of $5 million.

### Income Taxes on Continuing Operations

The effective tax rate on continuing operations decreased 420 basis points to 23.4%. The decline was due to impacts from excess tax benefits associated with share-based payments due to the adoption of FASB Accounting Standards Update (ASU) 2016-09 Improvements to Employee Share-based Payment Accounting (180 basis points), discrete impacts related to uncertain income tax positions (which netted to 140 basis points in the current year versus zero in the prior year), and the prior year establishment of a valuation allowance on deferred tax assets related to net operating loss carryforwards (270 basis points). These benefits were partially offset by unfavorable geographic mix, primarily due to a higher proportion of U.S. earnings.

### Net Earnings from Continuing Operations

Net earnings from continuing operations increased $219 million or 9% to $2.6 billion for the quarter. This increase was driven by the lower effective tax rate and reduced interest expense along with a 1% increase in operating income. Foreign exchange impacts reduced net earnings by about $80 million for the quarter due to weakening of certain key currencies against the U.S. dollar, primarily the currencies of Egypt, Turkey and the United Kingdom. This impact includes both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Diluted net earnings per share from continuing operations increased 15% to $0.93 due to the increase in net earnings and a reduction in number of weighted average shares outstanding following the shares tendered in the sale of the Beauty Brands to Coty (see Note 11 to the Consolidated Financial Statements), along with ongoing share repurchases.

### Discontinued Operations

Net earnings from discontinued operations were zero in the current period versus $446 million in the prior year. The base period result was driven primarily by a gain on sale of the Batteries business. The sale of the Beauty Brands closed in the second fiscal quarter of the current year. Accordingly, there are no results of discontinued operations reported in the quarter ended March 31, 2017 (see Note 11 to the Consolidated Financial Statements).

### Net Earnings

Net earnings attributable to Procter & Gamble decreased $228 million or 8% to $2.5 billion for the quarter. The decrease was driven by a reduction in earnings from discontinued operations, partially offset by the increase in earnings from continuing operations, both discussed above. Diluted net earnings per share decreased 4% to $0.93. The difference between the decrease in net earnings and the decrease in the related earnings per share was due to the reduction in weighted average shares outstanding discussed above. Core net earnings per share increased 12% to $0.96. Core net earnings per share represents diluted net earnings per share from continuing operations excluding incremental restructuring charges related to our productivity and cost savings plans.

### RESULTS OF OPERATIONS – Nine Months Ended March 31, 2017

The following discussion provides a review of results for the nine months ended March 31, 2017 versus the nine months ended March 31, 2016.

*Amounts in millions, except per share amounts*

|  | Nine Months Ended March 31 2017 | 2016 | % Chg |
| --- | ---: | ---: | ---: |
| Net sales | **$48,979** | $49,197 | —% |
| Operating income | **11,006** | 10,939 | 1% |
| Net earnings from continuing operations | **7,992** | 8,019 | —% |
| Net earnings from discontinued operations | **5,217** | 627 | N/A |
| Net earnings attributable to Procter & Gamble | **13,111** | 8,557 | 53% |
| Diluted net earnings per common share | **4.76** | 3.00 | 59% |
| Diluted net earnings per share from continuing operations | **2.87** | 2.78 | 3% |
| Core net earnings per common share | **3.07** | 2.88 | 7% |
|  | **Nine Months Ended March 31** |  |  |
| **COMPARISONS AS A % OF NET SALES** | **2017** | **2016** | **Basis Pt Chg** |
| Gross profit | **50.5%** | 50.1% | 40 |
| Selling, general & administrative expense | **28.0%** | 27.9% | 10 |
| Operating income | **22.5%** | 22.2% | 30 |
| Earnings from continuing operations before income taxes | **21.1%** | 21.7% | (60) |
| Net earnings from continuing operations | **16.3%** | 16.3% | — |
| Net earnings attributable to Procter & Gamble | **26.8%** | 17.4% | 940 |

### Net Sales

Net sales fiscal year to date were unchanged versus the previous period at $49.0 billion. Unit volume increased 1%. Unfavorable foreign exchange reduced net sales by 2%. Pricing and mix had no net impact on consolidated net sales. Volume increased mid-single digits in Health Care and low single digits in Grooming, Fabric & Home Care and in Baby, Feminine & Family Care. Volume decreased low single digits in Beauty driven by minor brand divestitures. Volume increased low single digits in developed regions and was unchanged in developing regions. Organic sales increased 2% driven by a 2% increase in organic volume.

|  | Net Sales Change Drivers 2017 vs. 2016 (Nine Months Ended March 31)\* Volume with Acquisitions & Divestitures | Volume Excluding Acquisitions & Divestitures | Foreign Exchange | Price | Mix | Other\*\* | Net Sales Growth |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Beauty | (2)% | 1% | (2)% | 1% | 1% | 1% | (1)% |
| Grooming | 1% | 2% | (2)% | —% | (2)% | —% | (3)% |
| Health Care | 4% | 5% | (2)% | 1% | 1% | —% | 4% |
| Fabric & Home Care | 1% | 2% | (2)% | (1)% | 1% | —% | (1)% |
| Baby, Feminine & Family Care | 2% | 3% | (2)% | (1)% | (1)% | 1% | (1)% |
| **Total Company** | **1%** | **2%** | **(2)%** | **—%** | **—%** | **1%** | **—%** |

\* Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

\*\* Other includes the sales mix impact from acquisitions/divestitures and rounding impacts necessary to reconcile volume to net sales.

### Operating Costs

Gross margin increased 40 basis points to 50.5% of net sales for the fiscal year to date period. Gross margin increased primarily due to a 220 basis point positive impact from total manufacturing cost savings (190 basis points net of product and packaging reinvestments) along with minor benefits from lower incremental restructuring charges and increased volume scale leverage. These impacts were partially offset by a 50 basis point negative impact from unfavorable foreign exchange, a 60 basis point decline from unfavorable product mix (primarily between segments caused by the lower relative proportion of sales in Beauty and Grooming, both of which have higher than company-average gross margins, and within segments due to disproportionate growth of lower margin products) and 50 basis points of combined negative impact from higher commodities and other costs.

Total SG&A spending was unchanged at $13.7 billion. SG&A as a percentage of net sales increased 10 basis points to 28.0%. Marketing spending as a percentage of net sales increased 60 basis points due to an increase in advertising and other activities, partially offset by productivity savings. Overhead costs as a percentage of net sales increased 30 basis points due to wage inflation and investments in R&D and sales resources. These impacts were partially offset by an 80 basis point decline in other operating expense due to reduced net foreign exchange transactional costs and a gain on the sale of real estate.

### Non-Operating Expenses and Income

Interest expense was $349 million for the fiscal year to date period, a decrease of $80 million versus the prior year period, due to a decrease in weighted average interest rates and a decline in the average debt outstanding. Interest income was $123 million for the fiscal year to date period, a decrease of $12 million versus the prior year period due to a decrease in the average balance of interest-bearing cash and cash equivalents. Other non-operating income/(loss) was $(450) million, a decrease of $488 million, primarily due to a $543 million charge related to early extinguishment of long-term debt incurred in the second fiscal quarter.

### Income Taxes on Continuing Operations

The effective tax rate on continuing operations decreased 230 basis points to 22.6%. The rate declined due to excess tax benefits associated with share-based payments due to the adoption of FASB Accounting Standards Update (ASU) 2016-09 Improvements to Employee Share-based Payment Accounting (180 basis points), discrete impacts related to uncertain income tax positions (which netted to 160 basis points in the current year versus 50 basis points in the prior year), the tax impact of the early retirement of certain debts (70 basis points) and the prior year establishment of a valuation allowance on deferred tax assets related to net operating loss carryforwards (80 basis points). These benefits were partially offset by unfavorable geographic mix, primarily due to a higher proportion of U.S. earnings.

### Net Earnings from Continuing Operations

Net earnings from continuing operations was unchanged at $8.0 billion for the fiscal year to date period. A reduction in earnings before tax, primarily driven by a $345 million after-tax charge related to the early extinguishment of long-term debt, was offset by the lower effective tax rate. Operating income increased 1% due to the improvement in gross margin discussed above. Foreign exchange impacts reduced net earnings by about $420 million fiscal year to date due to weakening of certain key currencies against the U.S. dollar, primarily the currencies of Argentina, Egypt, Nigeria and the United Kingdom. This impact includes both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Diluted net earnings per share from continuing operations increased 3% to $2.87 due to the decline in the number of weighted average shares outstanding discussed above.

### Discontinued Operations

Net earnings from discontinued operations increased $4.6 billion to $5.2 billion in the current period versus $0.6 billion in the prior period. This change was driven by the $5.3 billion gain on the sale of the Beauty Brands in the second fiscal quarter of the current period, partially offset by the base period results, which included the net earnings of the Batteries and Beauty Brands businesses prior to divestiture, a gain on the sale of the Batteries business and impairment charges on the Batteries business prior to divestiture (see Note 11 to the Consolidated Financial Statements).

### Net Earnings

Net earnings attributable to Procter & Gamble increased $4.6 billion or 53% to $13.1 billion for the fiscal year to date period. The increase was driven by the gain on the sale of the Beauty Brands and lower effective tax rate, partially offset by the charge related to the early extinguishment of debt, each discussed above. Diluted net earnings per share increased 59% to $4.76. The difference between the increase in net earnings attributable to Procter & Gamble and the increase in the related earnings per share was due to the reduction in weighted average shares outstanding discussed above. Core net earnings per share increased 7% to $3.07. Core net earnings per share represents diluted net earnings per share from continuing operations excluding the charge related to early extinguishment of long-term debt and incremental restructuring charges related to our productivity and cost savings plans.

### BUSINESS SEGMENT DISCUSSION – Three and Nine Months Ended March 31, 2017

The following discussion provides a review of results by reportable business segment. Analyses of the results for the three and nine month periods ended March 31, 2017 are provided based on a comparison to the same three and nine month periods ended March 31, 2016. The primary financial measures used to evaluate segment performance are net sales and net earnings from continuing operations. The table below provides supplemental information on net sales and net earnings from continuing operations by reportable business segment for the three and nine months ended March 31, 2017 versus the comparable prior year periods (dollar amounts in millions):

|  | Three Months Ended March 31, 2017 Net Sales | % Change Versus Year Ago | Earnings/(Loss) from Continuing Operations Before Income Taxes | % Change Versus Year Ago | Net Earnings/(Loss) from Continuing Operations | % Change Versus Year Ago |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Beauty | $2,675 | (2)% | $531 | (12)% | $396 | (14)% |
| Grooming | 1,525 | (6)% | 437 | (7)% | 333 | (6)% |
| Health Care | 1,841 | 4% | 470 | 14% | 310 | 12% |
| Fabric & Home Care | 4,957 | (1)% | 972 | (4)% | 599 | (8)% |
| Baby, Feminine & Family Care | 4,471 | (1)% | 890 | (9)% | 555 | (12)% |
| Corporate | 136 | 28% | 36 | N/A | 363 | N/A |
| **Total Company** | **$15,605** | **(1)%** | **$3,336** | **3%** | **$2,556** | **9%** |

|  | Nine Months Ended March 31, 2017 Net Sales | % Change Versus Year Ago | Earnings/(Loss) from Continuing Operations Before Income Taxes | % Change Versus Year Ago | Net Earnings/(Loss) from Continuing Operations | % Change Versus Year Ago |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Beauty | $8,613 | (1)% | $2,028 | (8)% | $1,528 | (8)% |
| Grooming | 4,972 | (3)% | 1,580 | 2% | 1,217 | 3% |
| Health Care | 5,774 | 4% | 1,574 | 10% | 1,052 | 6% |
| Fabric & Home Care | 15,529 | (1)% | 3,226 | (3)% | 2,052 | (6)% |
| Baby, Feminine & Family Care | 13,711 | (1)% | 2,973 | (5)% | 1,932 | (6)% |
| Corporate | 380 | 17% | (1,051) | N/A | 211 | N/A |
| **Total Company** | **$48,979** | **—%** | **$10,330** | **(3)%** | **$7,992** | **—%** |

#### Beauty

#### Three months ended March 31, 2017 compared with three months ended March 31, 2016

Beauty net sales decreased 2% to $2.7 billion during the third fiscal quarter on a 2% decrease in unit volume. Unfavorable foreign exchange reduced net sales by 1%. Price increases added 1% to net sales. Organic sales increased 1% on organic volume that was unchanged. Global market share of the Beauty segment decreased 0.6 points. Volume decreased mid-single digits in developed regions and was unchanged in developing regions. Excluding the impact of minor brand divestitures, organic volume increased low single digits in developing regions.

- Volume in Hair Care decreased low single digits due to minor brand divestitures. Organic volume increased low single digits. Developed market volume decreased mid-single digits following increased pricing and due to competitive activity and reduced customer inventory. Developing regions declined low single digits due to minor brand divestitures. Organic volume increased low single digits in developing regions behind product innovation, increased marketing spending and market growth. Global market share of the Hair Care category decreased half a point.
- Volume in Skin and Personal Care decreased low single digits. Volume decreased high single digits in developed regions following increased pricing and reduced promotional events at certain customers. Volume increased low single digits in developing regions due to product innovation and increased marketing. Global market share of the Skin and Personal Care category decreased more than half a point.

Net earnings decreased 14% to $396 million due to the reduction in net sales and a 210 basis point decrease in net earnings margin. The net earnings margin declined primarily due to an increase in SG&A as a percentage of net sales. SG&A as a percentage of net sales increased due to increased marketing spending to support initiatives and increased overhead spending on sales resources. Gross margin decreased slightly as higher commodity costs and unfavorable mix impacts in Hair Care (primarily from an increase in the proportion of lower margin brands along with unfavorable geographic mix) were only partially offset by productivity savings and the benefit of higher pricing.

#### Nine months ended March 31, 2017 compared with nine months ended March 31, 2016

Beauty fiscal year to date net sales decreased 1% to $8.6 billion on a 2% decrease in unit volume. Unfavorable foreign exchange reduced net sales by 2%. Increased pricing added 1% to net sales and favorable product mix also added 1% primarily due to growth of the super-premium SK-II brand, which has higher than average selling prices. Organic sales increased 2% on organic volume that increased 1%. Global market share of the Beauty segment decreased 0.7 points. Volume decreased low single digits in developed regions. Volume also decreased low single digits in developing regions, mainly due to minor brand divestitures, but increased mid-single digits on an organic basis.

- Volume in Hair Care decreased low single digits due to minor brand divestitures. Organic volume increased low single digits. Developed regions declined low single digits mainly due to competitive activity and developing regions declined low single digits due to minor brand divestitures. Organic volume increased mid-single digits in developing regions behind product innovation, increased marketing and market growth. Global market share of the Hair Care category decreased less than a point.
- Volume in Skin and Personal Care decreased low single digits. Developed market volume decreased low single digits following increased pricing and due to competitive activity. Volume increased low single digits in developing regions including the impact of minor brand divestitures. Organic volume was up mid-single digits in developing regions behind innovation, increased marketing and market growth. Global market share of the Skin and Personal Care category decreased half a point.

Net earnings decreased 8% to $1.5 billion due to the reduction in net sales and a 140 basis point decrease in net earnings margin, behind an increase in SG&A as a percentage of net sales. SG&A as a percentage of net sales increased due to increased marketing spending to support initiatives and increased overhead spending on sales resources. Gross margin decreased slightly as the benefits from productivity savings and higher pricing were more than offset by higher commodity costs and unfavorable mix impacts (primarily from an increase in the proportion of lower margin brands along with unfavorable geographic mix).

#### Grooming

#### Three months ended March 31, 2017 compared with three months ended March 31, 2016

Grooming net sales decreased 6% to $1.5 billion during the third fiscal quarter on unit volume that was unchanged. Price reductions in Shave Care reduced net sales by 2%. Unfavorable geographic mix reduced net sales by 4% driven by decline in developed markets, where average selling prices are higher than in developing regions. Organic sales decreased 6% on organic volume that was unchanged. Global market share of the Grooming segment decreased 0.5 points. Volume decreased mid-single digits in developed regions and increased low single digits in developing regions.

- Shave Care volume decreased low single digits. Shave Care volume decreased high single digits in developed regions due to competitive activity and increased mid-single digits in developing regions behind product innovation. Global market share of the Shave Care category decreased more than half a point.
- Volume in Appliances increased double digits. Volume was up double digits in developed regions due to product innovation and decreased mid-single digits in developing regions following increased pricing. Global market share of the Appliances category increased more than a point.

Net earnings decreased 6% to $333 million due to the reduction in net sales. Net earnings margin decreased 10 basis points as an increase in SG&A as a percent of net sales more than offset an increase in gross margin. SG&A as a percent of net sales increased due to an increase in overhead spending. Gross margin increased as the benefit of cost savings projects more than offset the negative impact of lower pricing and unfavorable geographic mix (from the disproportionate decline of developed market volume, which has higher than segment-average margin).

#### Nine months ended March 31, 2017 compared with nine months ended March 31, 2016

Grooming fiscal year to date net sales decreased 3% to $5.0 billion on a 1% increase in unit volume. Unfavorable foreign exchange reduced net sales by 2%. Unfavorable geographic mix reduced net sales by 2% driven by growth in emerging markets, where average selling prices are lower than in developed regions, in part due to a higher relative proportion of disposable razors in those markets. Organic sales were unchanged on organic volume that increased 2%. Global market share of the Grooming segment decreased 0.5 points. Volume decreased low single digits in developed regions and increased low single digits in developing regions.

- Shave Care volume increased low single digits. Shave Care volume decreased low single digits in developed regions due to competitive activity and increased low single digits in developing regions behind product innovation and increased marketing support. Organic volume increased mid-single digits in developing regions. Global market share of the Shave Care category decreased half a point.
- Volume in Appliances increased high single digits. Volume was up double digits in developed regions and low single digits in developing regions due to product innovation. Global market share of the Appliances category increased more than half a point.

Net earnings increased 3% to $1.2 billion due to a 120 basis-point increase in net earnings margin which more than offset the reduction in net sales. Net earnings margin improved behind both gross margin expansion and a reduction in SG&A as a percent of net sales. Gross margin increased as the benefits of productivity efforts were only partially offset by unfavorable foreign exchange impacts and negative product mix driven by the disproportionate growth of disposable razors, which have below segment-average margins. SG&A as a percent of net sales decreased due to a gain on the sale of real estate partially offset by increased overhead and marketing spending.

#### Health Care

#### Three months ended March 31, 2017 compared with three months ended March 31, 2016

Health Care net sales increased 4% to $1.8 billion during the third fiscal quarter on a 4% increase in unit volume. Unfavorable foreign exchange reduced net sales by 1%. Price increases contributed 1% to net sales and favorable product mix added 1% to net sales, primarily due to an increase in Oral Care power toothbrushes, which have higher than average selling prices. Organic sales increased 6% on organic volume that increased 4%. Global market share of the Health Care segment decreased 0.1 points. Volume increased low single digits in developed regions and increased mid-single digits in developing regions.

- Oral Care volume increased mid-single digits. Volume increased mid-single digits in developed regions and high single digits in developing regions driven by market growth and product innovation. Global market share of the Oral Care category was unchanged.
- Volume in Personal Health Care was unchanged including the impact of minor brand divestitures. Organic volume increased low single digits globally and in developed regions with mid-single-digit growth in developing regions behind market growth, product innovation and expanded distribution. Global market share of the Personal Health Care category increased slightly.

Net earnings increased 12% to $310 million due to the increase in net sales and a 120 basis point increase in net earnings margin. Gross margin increased due to manufacturing cost savings and increased pricing, partially offset by unfavorable geographic mix, due to the disproportionate growth of developing regions which have lower than segment-average margins. SG&A as a percentage of net sales declined due to the scale benefit of the increase in net sales.

#### Nine months ended March 31, 2017 compared with nine months ended March 31, 2016

Health Care fiscal year to date net sales increased 4% to $5.8 billion on a 4% increase in unit volume. Unfavorable foreign exchange reduced net sales by 2%. Price increases contributed 1% to net sales. Favorable product mix increased net sales 1%, primarily driven by an increase in Oral Care power toothbrushes which have higher than average selling prices. Organic sales increased 7% on organic volume that increased 5%. Global market share of the Health Care segment decreased 0.1 points. Volume increased low single digits in developed regions and increased mid-single digits in developing regions.

- Oral Care volume increased mid-single digits in both developed and developing regions driven by market growth and product innovation. Global market share of the Oral Care category was unchanged.
- Volume in Personal Health Care increased low single digits with low single-digit growth in developed regions and mid-single-digit growth in developing regions behind market growth, product innovation and expanded distribution. Global market share of the Personal Health Care category was unchanged.

Net earnings increased 6% to $1.1 billion due to the increase in net sales and a 40 basis point increase in net earnings margin. The operating margin improvement was driven by higher gross margin, partially offset by increased SG&A as a percentage of net sales. Gross margin increased due to productivity cost savings and pricing benefits, partially offset by unfavorable foreign exchange impacts and unfavorable geographic mix due to the disproportionate growth of developing regions which have lower than segment-average margins. SG&A increased as a percentage of net sales due to increased overhead spending and a base period benefit related to our PGT Healthcare partnership.

#### Fabric & Home Care

#### Three months ended March 31, 2017 compared with three months ended March 31, 2016

Fabric & Home Care net sales decreased 1% to $5.0 billion for the third fiscal quarter on unit volume that was unchanged. Unfavorable foreign exchange reduced net sales by 2%. Organic sales increased 1% on organic volume that increased 1%. Global market share of the Fabric & Home Care segment decreased 0.1 points. Volume increased low single digits in developed regions and decreased low single digits in developing regions.

- Fabric Care volume was unchanged as a low single-digit increase in developed regions due to product innovation was offset by a low single-digit decrease in developing regions driven primarily by competitive activities. Global market share of the Fabric Care category decreased slightly.
- Home Care volume increased low single digits. Developed market volume was unchanged while developing regions increased low single digits due to product innovation. Global market share of the Home Care category was unchanged.

Net earnings decreased 8% to $599 million due to a 90 basis-point decrease in net earnings margin and the reduction in net sales. Net earnings margin decreased due to an increase in SG&A as a percent of net sales and lower gross margin. SG&A as a percentage of net sales increased due to increased overhead spending. Gross margin decreased due to unfavorable product mix (due to an increase in the proportion of product forms and larger package sizes with lower than segment-average margins) and increased commodity costs partially offset by manufacturing cost savings.

#### Nine months ended March 31, 2017 compared with nine months ended March 31, 2016

Fabric & Home Care fiscal year to date net sales decreased 1% to $15.5 billion on a 1% increase in unit volume. Unfavorable foreign exchange reduced net sales by 2%. Lower pricing driven by promotional spending had a negative 1% impact on net sales. Favorable geographic mix increased net sales 1%, primarily driven by increased volume in developed regions, which have higher than segment-average selling prices. Organic sales increased 2% on organic volume that increased 2%. Global market share of the Fabric & Home Care segment was unchanged. Volume increased low single digits in developed regions and decreased low single digits in developing regions.

- Fabric Care volume increased low single digits as a mid-single-digit increase in developed regions due to innovation and increased marketing spending was partially offset by a low single-digit decrease in developing regions driven by competitive activity and reduced distribution of less profitable brands. Global market share of the Fabric Care category was unchanged.
- Home Care volume increased low single digits driven by a low single-digit increase in developed regions due to product innovation. Volume was unchanged in developing regions including minor brand divestitures. Organic volume in developing regions increased low single digits due to product innovation. Global market share of the Home Care category was unchanged.

Net earnings decreased 6% to $2.1 billion behind a 70 basis-point decrease in net earnings margin along with the reduction in net sales. Net earnings margin decreased due to an increase in SG&A as a percent of net sales, partially offset by higher gross margin. SG&A as a percentage of net sales increased due to increased marketing and overhead spending. Gross margin expansion was driven by manufacturing cost savings, partially offset by unfavorable foreign exchange impacts, increased commodity costs and lower pricing.

#### Baby, Feminine & Family Care

#### Three months ended March 31, 2017 compared with three months ended March 31, 2016

Baby, Feminine & Family Care net sales decreased 1% to $4.5 billion during the third fiscal quarter on a 1% increase in unit volume. Unfavorable foreign exchange reduced net sales by 1%. Organic sales increased 1% on organic volume that increased 1%. Global market share of the Baby, Feminine & Family Care segment was unchanged. Volume increased low single digits in developed regions and decreased low single digits in developing regions.

- Volume in Baby Care decreased low single digits caused by a low single-digit decrease in developing regions primarily due to competitive activity. Volume was unchanged in developed regions. Global market share of the Baby Care category decreased a point.
- Volume in Feminine Care increased low single digits. Volume increased low single digits in developed regions due to product innovation and was unchanged in developing regions. Global market share of the Feminine Care category was unchanged.
- Volume in Family Care, which is predominantly a North American business, increased mid-single digits driven by product innovation and increased marketing support. In the U.S., all-outlet share of the Family Care category increased more than a point.

Net earnings decreased 12% to $555 million due to a 160 basis point decrease in net earnings margin and the reduction in net sales. Net earnings margin decreased due to a decline in gross margin and an increase in SG&A as a percent of sales. Gross margin decreased due to unfavorable product mix from an increase in product forms and larger package sizes with lower than segment-average margins and costs incurred from tornado damage to a U.S. distribution facility, partially offset by manufacturing cost savings. SG&A as a percentage of net sales increased driven by higher marketing and overhead spending.

#### Nine months ended March 31, 2017 compared with nine months ended March 31, 2016

Baby, Feminine & Family Care net sales decreased 1% to $13.7 billion during the fiscal year to date on a 2% increase in unit volume. Unfavorable foreign exchange reduced net sales by 2%. Lower pricing driven by promotional spending had a negative 1% impact on net sales. Unfavorable product mix reduced net sales by 1% due to the disproportionate growth of Family Care which has lower than segment-average selling prices. Organic sales increased 1% on organic volume that increased 3%. Global market share of the Baby, Feminine & Family Care segment decreased 0.1 points. Volume increased low single digits in both developed and developing regions.

- Volume in Baby Care increased low single digits driven by a low single-digit increase in developing regions due to market growth, product innovation and decreased pricing, partially offset by competitive activity. Volume decreased low single digits in developed regions due to competitive activity. Global market share of the Baby Care category decreased more than half a point.
- Volume in Feminine Care increased low single digits due to a low single-digit increase in developed regions driven by product innovation and market growth. Developing region volume was unchanged. Global market share of the Feminine Care category was unchanged.
- Volume in Family Care, which is predominantly a North America business, increased mid-single digits driven by product innovation and increased merchandising. In the U.S., all-outlet share of the family care category increased nearly a point.

Net earnings decreased 6% to $1.9 billion due to the reduction in net sales and an 80 basis point decrease in net earnings margin as increased SG&A as a percent of net sales was only partially offset by increased gross margin. SG&A as a percentage of net sales increased due to increased marketing and overhead spending. Gross margin increased driven by manufacturing cost savings partially offset by unfavorable foreign exchange impacts, lower pricing and unfavorable product mix across business units due to an increase in product forms and larger package sizes with lower than segment-average margins.

#### Corporate

Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the gains and losses related to certain divested brands and categories; certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization; certain significant asset impairment charges; and certain balance sheet impacts from significant foreign exchange devaluations. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling item includes income taxes to adjust from blended statutory rates that are reflected in the segments to the overall Company effective tax rate.

Corporate net sales increased 28% to $136 million during the third fiscal quarter and increased 17% to $380 million fiscal year to date both primarily due to an increase in the incidental businesses managed at the corporate level. Corporate net earnings from continuing operations improved by $401 million in the third fiscal quarter and by $271 million fiscal year to date. Corporate net earnings increased in the third quarter due to 1) a current fiscal year sale of real estate, 2) lower restructuring charges compared to the prior year, 3) an increase in the proportion of corporate overhead spending which is allocated to the segments, consisting in part of stranded overheads from divestiture, and 4) current year tax benefits resulting from the adoption of a new accounting standard on the tax impacts of share-based payments to employees (see Note 2 to the Consolidated Financial Statements). Corporate net earnings increased fiscal year to date due to the reasons affecting the third quarter discussed above, partially offset by a $345 million after-tax charge on the early extinguishment of long-term debt during the second quarter.

### Productivity and Cost Savings Plan

In 2012, the Company initiated a productivity and cost savings plan to reduce costs and better leverage scale in the areas of supply chain, research and development, marketing and overheads. The plan was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes to fund the Company's growth strategy.

As part of this plan, which has been expanded since its inception, the Company expects to incur approximately $5.5 billion in before-tax restructuring costs over a six-year period (from fiscal 2012 through fiscal 2017). Approximately 98% of the estimated costs have been incurred through March 2017. Savings generated from the restructuring costs are difficult to estimate, given the nature of the activities, the corollary benefits achieved (e.g., enrollment reduction achieved via normal attrition), the timing of the execution and the degree of reinvestment. Overall, the costs and other non-manufacturing enrollment reductions are expected to deliver approximately $3 billion in annual gross savings (before-tax). The cumulative before-tax savings as of the current year are estimated at approximately $2.5 to $3 billion. Consistent with our historical policies for ongoing restructuring-type activities, the resulting charges are funded by and included within Corporate for segment reporting.

Refer to Note 9 in the Notes to the Consolidated Financial Statements for more details on the restructuring program.

### LIQUIDITY & CAPITAL RESOURCES

#### Operating Activities

We generated $9.1 billion of cash from operating activities fiscal year to date, a decrease of $2.2 billion versus the prior year. Net earnings, adjusted for non-cash items (depreciation and amortization, loss on early extinguishment of debt, share-based compensation expense, deferred income taxes, and gain on sale of businesses), generated $10.2 billion of operating cash flow. Working capital and other impacts used $1.1 billion of cash in the period. Accounts receivable used $159 million of cash due to sales growth late in the quarter partially offset by collection of approximately $150 million of retained receivables from the Beauty Brands business. Inventory consumed $145 million of cash due to product initiatives and business growth in certain GBUs and reduced consumption in certain other GBUs. Accounts payable, accrued and other liabilities used $1.1 billion of cash primarily due to the payment of prior fiscal year accruals and the impacts of the Beauty Brands divestiture, including the payment of approximately $450 million of accounts payable and accrued liabilities retained by the company pursuant to the terms of the agreement. We also paid $204 million of taxes related to the divestiture. All other operating assets and liabilities generated $267 million of cash.

#### Investing Activities

Cash used by investing activities was $3.8 billion fiscal year to date. Capital expenditures were $2.2 billion, or 4.6% of net sales. We generated $411 million of cash from proceeds from asset sales primarily from building sales and minor brand divestitures. We initially invested $874 million of cash, received from the pre-Beauty Brands divestiture issuance of transaction-related debt, in restricted cash. We transferred $475 million of cash at closing to the discontinued Beauty Brands. At transaction closing, cumulative restricted cash of $1.9 billion was released and returned to cash and cash equivalents. We used $3.4 billion for purchases of short-term investments, partially offset by $834 million of cash generated from proceeds from sales and maturities of short-term investments.

#### Financing Activities

Our financing activities consumed net cash of $6.3 billion fiscal year to date. We used $4.5 billion for treasury stock purchases and $5.4 billion for dividends. Cash generated from the net effect of debt issuances and payments was $1.2 billion. Cash from the exercise of stock options and other impacts generated $2.4 billion of cash.

As of March 31, 2017, our current liabilities exceeded current assets by $3.2 billion. We have short- and long-term debt to meet our financing needs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings that have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements.

### RECONCILIATION OF MEASURES NOT DEFINED BY U.S. GAAP

In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures and the reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.

The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:

Incremental restructuring: The Company has had and continues to have an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. Beginning in 2012 Procter & Gamble began a $10 billion strategic productivity and cost savings initiative that includes incremental restructuring activities. This results in incremental restructuring charges to accelerate productivity efforts and cost savings. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs.

Early debt extinguishment charges: During the three months ended December 31, 2016, the Company recorded a charge of $345 million after tax due to the early extinguishment of certain long-term debt. This charge represents the difference between the reacquisition price and the par value of the debt extinguished. Management does not view this charge as indicative of the Company’s operating performance or underlying business results.

Charges for certain European legal matters: Several countries in Europe issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in prior periods. The Company established Legal Reserves related to these charges. Management does not view these charges as indicative of underlying business results.

We do not view the above items to be part of our sustainable results and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.

Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons. Management believes this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis.

Adjusted free cash flow: Adjusted free cash flow is defined as operating cash flow less capital spending and excluding tax payments related to the Beauty Brands divestiture, which are non-recurring and not considered indicative of underlying cash flow performance. Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends and discretionary investment.

Adjusted free cash flow productivity: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the loss on early debt extinguishment and gain on the sale of the Beauty Brands, which are non-recurring and not considered indicative of underlying earnings performance. Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes. The Company's long-term target is to generate annual adjusted free cash flow productivity at or above 90 percent.

Core EPS: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time.

Organic sales growth:

| Three Months Ended March 31, 2017 | Net Sales Growth | Foreign Exchange Impact | Acquisition/Divestiture Impact\* | Organic Sales Growth |
| --- | ---: | ---: | ---: | ---: |
| Beauty | (2)% | 1% | 2% | 1% |
| Grooming | (6)% | —% | —% | (6)% |
| Health Care | 4% | 1% | 1% | 6% |
| Fabric & Home Care | (1)% | 2% | —% | 1% |
| Baby, Feminine & Family Care | (1)% | 1% | 1% | 1% |
| **Total Company** | **(1)%** | **2%** | **—%** | **1%** |

| Nine Months Ended March 31, 2017 | Net Sales Growth | Foreign Exchange Impact | Acquisition/Divestiture Impact\* | Organic Sales Growth |
| --- | ---: | ---: | ---: | ---: |
| Beauty | (1)% | 2% | 1% | 2% |
| Grooming | (3)% | 2% | 1% | —% |
| Health Care | 4% | 2% | 1% | 7% |
| Fabric & Home Care | (1)% | 2% | 1% | 2% |
| Baby, Feminine & Family Care | (1)% | 2% | —% | 1% |
| **Total Company** | **—%** | **2%** | **—%** | **2%** |

\* Acquisition/Divestiture Impact includes the mix impacts of acquisitions and divestitures and rounding impacts necessary to reconcile net sales to organic sales.

Adjusted free cash flow (dollar amounts in millions):

*Fiscal Year-to-Date, March 31, 2017*

| Operating Cash Flow | Capital Spending | Free Cash Flow | Cash Tax Payment - Beauty Sale | Adjusted Free Cash Flow |
| ---: | ---: | ---: | ---: | ---: |
| **$9,065** | **$(2,230)** | **$6,835** | **$204** | **$7,039** |

Adjusted free cash flow productivity (dollar amounts in millions):

*Fiscal Year-to-Date, March 31, 2017*

| Adjusted Free Cash Flow | Net Earnings | Loss on Early Debt Extinguishment | Gain on Sale of Beauty Brands | Adjusted Net Earnings | Adjusted Free Cash Flow Productivity |
| ---: | ---: | ---: | ---: | ---: | ---: |
| **$7,039** | **$13,209** | **$345** | **$(5,335)** | **$8,219** | **86%** |

*THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures*

*Three Months Ended March 31, 2017*

|  | AS REPORTED (GAAP) | INCREMENTAL RESTRUCTURING | ROUNDING | NON-GAAP (CORE) |
| --- | ---: | ---: | ---: | ---: |
| **COST OF PRODUCTS SOLD** | 7,836 | (113) | 1 | 7,724 |
| **SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE** | 4,409 | 22 | (1) | 4,430 |
| **OPERATING INCOME** | 3,360 | 91 | — | 3,451 |
| **INCOME TAX ON CONTINUING OPERATIONS** | 780 | 21 | (1) | 800 |
| **NET EARNINGS ATTRIBUTABLE TO P&G** | 2,522 | 70 | — | 2,592 |
|  |  |  |  | **Core EPS** |
| **DILUTED NET EARNINGS PER COMMON SHARE\*** | 0.93 | 0.03 | — | 0.96 |

\* Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

| CHANGE VERSUS YEAR AGO |  |
| --- | ---: |
| CORE EPS | 12% |

*THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures*

*Three Months Ended March 31, 2016*

|  | AS REPORTED (GAAP) | DISCONTINUED OPERATIONS | INCREMENTAL RESTRUCTURING | CHARGES FOR EUROPEAN LEGAL MATTERS | ROUNDING | NON-GAAP (CORE) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **COST OF PRODUCTS SOLD** | 7,915 | — | (174) | — | — | 7,741 |
| **SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE** | 4,522 | — | 14 | (13) | (1) | 4,522 |
| **OPERATING INCOME** | 3,318 | — | 160 | 13 | 1 | 3,492 |
| **INCOME TAX ON CONTINUING OPERATIONS** | 889 | — | 33 | 2 | (1) | 923 |
| **NET EARNINGS ATTRIBUTABLE TO P&G** | 2,750 | (445) | 127 | 11 | — | 2,443 |
|  |  |  |  |  |  | **Core EPS:** |
| **DILUTED NET EARNINGS PER COMMON SHARE\*** | 0.97 | (0.16) | 0.04 | — | 0.01 | 0.86 |

\* Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

*THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures*

*Nine Months Ended March 31, 2017*

|  | AS REPORTED (GAAP) | DISCONTINUED OPERATIONS | INCREMENTAL RESTRUCTURING | EARLY DEBT EXTINGUISHMENT | ROUNDING | NON-GAAP (CORE) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **COST OF PRODUCTS SOLD** | 24,236 | — | (352) | — | 1 | 23,885 |
| **SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE** | 13,737 | — | 81 | — | (1) | 13,817 |
| **OPERATING INCOME** | 11,006 | — | 271 | — | — | 11,277 |
| **INCOME TAX ON CONTINUING OPERATIONS** | 2,338 | — | 57 | 198 | (1) | 2,592 |
| **NET EARNINGS ATTRIBUTABLE TO P&G** | 13,111 | (5,217) | 214 | 345 | — | 8,453 |
|  |  |  |  |  |  | **Core EPS** |
| **DILUTED NET EARNINGS PER COMMON SHARE\*** | 4.76 | (1.89) | 0.08 | 0.13 | (0.01) | 3.07 |

\* Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

| CHANGE VERSUS YEAR AGO |  |
| --- | ---: |
| CORE EPS | 7% |

*THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES (Amounts in Millions Except Per Share Amounts) Reconciliation of Non-GAAP Measures*

*Nine Months Ended March 31, 2016*

|  | AS REPORTED (GAAP) | DISCONTINUED OPERATIONS | INCREMENTAL RESTRUCTURING | CHARGES FOR EUROPEAN LEGAL MATTERS | ROUNDING | NON-GAAP (CORE) |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **COST OF PRODUCTS SOLD** | 24,527 | — | (389) | — | — | 24,138 |
| **SELLING, GENERAL, AND ADMINISTRATIVE EXPENSE** | 13,731 | — | 28 | (13) | (1) | 13,745 |
| **OPERATING INCOME** | 10,939 | — | 361 | 13 | 1 | 11,314 |
| **INCOME TAX ON CONTINUING OPERATIONS** | 2,664 | — | 77 | 2 | (1) | 2,742 |
| **NET EARNINGS ATTRIBUTABLE TO P&G** | 8,557 | (627) | 284 | 11 | 1 | 8,226 |
|  |  |  |  |  |  | **Core EPS:** |
| **DILUTED NET EARNINGS PER COMMON SHARE\*** | 3.00 | (0.22) | 0.10 | — | — | 2.88 |

\* Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

## Market risk

As filed, 242 characters.

There have been no material changes in the Company’s exposure to market risk since June 30, 2016. Additional information can be found in Note 7 - Risk Management Activities and Fair Value Measurements of the Consolidated Financial Statements.

## Controls and procedures

As filed, 1,280 characters.

### Evaluation of Disclosure Controls and Procedures

The Company’s Chairman of the Board, President and Chief Executive Officer, David S. Taylor, and the Company’s Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report. Messrs. Taylor and Moeller have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Taylor and Moeller, to allow their timely decisions regarding required disclosure.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2017 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 157 characters.

For information on Risk Factors, please refer to Part II, Item 1A "Risk Factors" in the Company’s Form 10-Q for the quarterly period ended December 31, 2016.

Filed Apr 26, 2017.
Source: SEC EDGAR, the filing index for accession 0000080424-17-000026. Last ingested by Listed: Nov 13, 2026, 16:40 ET. No prices; not investment advice.
